What is the next step for a 64-year-old woman with a horseshoe kidney and a suspected large urothelial cell tumor in the left upper pole?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Suspected Urothelial Cell Tumor in a Horseshoe Kidney

For a 64-year-old woman with a horseshoe kidney and suspected large urothelial cell tumor in the left upper pole, the next step should be a comprehensive diagnostic evaluation including CT urogram or retrograde pyelogram with ureteroscopy and biopsy to confirm diagnosis before proceeding to nephroureterectomy with bladder cuff and regional lymphadenectomy.

Initial Diagnostic Workup

  • CT urogram or retrograde pyelogram with ureteroscopy is essential to evaluate the suspected urothelial tumor in the upper pole of the horseshoe kidney 1
  • Chest radiograph to evaluate for possible metastatic disease and assess comorbid conditions 1
  • Urine cytology to help identify carcinoma cells 1
  • Complete hematologic, renal, and hepatic function evaluation 1
  • Additional imaging studies (bone scan) may be needed if indicated by initial test results or specific symptoms 1

Diagnostic Considerations in Horseshoe Kidney

  • Horseshoe kidney is the most common congenital renal fusion anomaly affecting 1 in 400-600 patients 2
  • Aberrant vascular anatomy in horseshoe kidneys requires careful preoperative planning 3
  • Angiography is essential to plan the surgical approach in horseshoe kidneys with tumors 4
  • Endoscopic assessment should confirm no other foci of disease 2

Treatment Approach

For High-Grade Tumors (Most Likely Scenario)

  • Nephroureterectomy with a cuff of bladder and regional lymphadenectomy is the standard treatment for high-grade upper tract urothelial tumors 1
  • In horseshoe kidneys, this involves splitting the isthmus and saving the contralateral moiety 3
  • The procedure can be performed using minimally invasive techniques (robotic or laparoscopic) when feasible 2, 5
  • Regional lymphadenectomy should be performed for high-grade tumors 1

For Well-Differentiated Tumors (If Confirmed by Biopsy)

  • Nephron-sparing options may include:
    • Transureteroscopic approach 1
    • Percutaneous approach with or without postsurgical intrapelvic chemotherapy or BCG 1

Post-Treatment Follow-up

  • For pathologic stage pT0 or pT1:

    • Serial cystoscopies at 3-month intervals for the first year, then every 6 months 1
    • Upper-tract imaging studies (IVP, retrograde pyelogram, CT or MRI urography) at 1-2 year intervals 1
    • Consider ureteroscopy at 3-12 month intervals if endoscopic resection was performed 1
  • For pathologic stage pT2, pT3, pT4, or nodal disease:

    • Consider adjuvant chemotherapy 1
    • Serial evaluations of the urothelial tract 1
    • Imaging studies to exclude metastatic disease 1

Important Considerations and Pitfalls

  • Horseshoe kidneys present unique challenges due to aberrant vascular anatomy and risk of renal insufficiency 3
  • Preservation of renal function is critical, with functional advantage observed for nephron-sparing surgery when feasible 3
  • Tumors in horseshoe kidneys can mimic intra-abdominal disease processes, particularly when arising in the isthmus 4
  • Careful preoperative planning is essential due to the variable blood supply patterns in horseshoe kidneys 4
  • In cases where nephroureterectomy is performed, a portion of the bladder must be removed to ensure complete removal of the entire intramural ureter 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.